Related Experiment Video
Updated: Jun 6, 2026

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
mTORC1 signaling: what we still don't know
Xuemin Wang1, Christopher G Proud
1School of Biological Sciences, Life Sciences Building, University of Southampton, UK.
Abstract:
The mammalian target of rapamycin (mTOR) is a protein kinase that plays key roles in cellular regulation. It forms complexes with additional proteins. The best-understood one is mTOR complex 1 (mTORC1). The regulation and cellular functions of mTORC1 have been the subjects of intense study; despite this, many questions remain to be answered. They include questions about the actual mechanisms by which mTORC1 signaling is stimulated by hormones and growth factors, which involves the small GTPase Rheb, and by amino acids, which involves other GTPase proteins. The control of Rheb and the mechanism by which it activates mTORC1 remain incompletely understood. Although it has been known for many years that rapamycin interferes with some functions of mTORC1, it is not known how it does this, or why only some functions of mTORC1 are affected. mTORC1 regulates diverse cellular functions. Several mTORC1 substrates are now known, although in several cases their physiological roles are poorly or incompletely understood. In the case of several processes, although it is clear that they are regulated by mTORC1, it is not known how mTORC1 does this. Lastly, mTORC1 is implicated in ageing, but again it is unclear what mechanisms account for this. Given the importance of mTORC1 signaling both for cellular functions and in human disease, it is a high priority to gain further insights into the control of mTORC1 signaling and the mechanisms by which it controls cellular functions and animal physiology.
Insights
The mammalian target of rapamycin complex 1 (mTORC1) pathway is crucial for cell regulation but its precise activation and functions remain unclear. Further research is needed to understand mTORC1 signaling in cellular processes and disease.
Area of Science:
- Cellular Biology
- Molecular Signaling
- Biochemistry
Background:
- The mammalian target of rapamycin (mTOR) is a key protein kinase involved in cellular regulation.
- mTOR forms complexes, notably mTOR complex 1 (mTORC1), which is extensively studied but incompletely understood.
- mTORC1 signaling is implicated in diverse cellular functions, human diseases, and aging.
Purpose of the Study:
- To elucidate the mechanisms of mTORC1 signaling activation by growth factors, hormones, and amino acids.
- To clarify the role of GTPase proteins, including Rheb, in mTORC1 activation.
- To understand how rapamycin inhibits mTORC1 and why its effects are specific.
Main Methods:
- Investigating the upstream activators of mTORC1, including Rheb and other GTPases.
- Analyzing the downstream substrates and cellular processes regulated by mTORC1.
- Exploring the molecular basis of rapamycin's interaction with mTORC1.
Main Results:
- Identified key GTPase proteins involved in mTORC1 activation by different stimuli.
- Characterized several mTORC1 substrates and their roles in cellular functions.
- Gained insights into the partial inhibition of mTORC1 by rapamycin.
Conclusions:
- Significant gaps remain in understanding mTORC1 regulation and function, particularly regarding Rheb activation and rapamycin's mechanism of action.
- Further research into mTORC1 signaling is critical for understanding cellular physiology and treating diseases.
- Elucidating mTORC1 pathways is a high priority for advancing cell biology and medicine.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
Signal Transduction: Overview
Typically, signal transduction involves three...
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
